Skip to main content

Food Effect

2
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 3 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Ildong Pharmaceutical
1 program
1
Besifovir dipivoxilPhase 41 trial
Active Trials
NCT03885778Completed15Est. Feb 2019
Ranok Therapeutics
Ranok TherapeuticsChina - Hangzhou
1 program
1
RNK08954Phase 11 trial
Active Trials
NCT07334262Not Yet Recruiting24Est. Dec 2026
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
SativexPHASE_11 trial
Active Trials
NCT01322464Completed25Est. Feb 2008
Hutchmed
HutchmedChina - Hong Kong
1 program
VolitinibPHASE_1Small Molecule1 trial
Active Trials
NCT02017236Completed25Est. Jun 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ildong PharmaceuticalBesifovir dipivoxil
Ranok TherapeuticsRNK08954
HutchmedVolitinib
Jazz PharmaceuticalsSativex

Clinical Trials (4)

Total enrollment: 89 patients across 4 trials

NCT03885778Ildong PharmaceuticalBesifovir dipivoxil

A Food Effect Study of Besifovir in Healthy Subjects

Start: Jan 2019Est. completion: Feb 201915 patients
Phase 4Completed
NCT07334262Ranok TherapeuticsRNK08954

A Study to Evaluate the Food Effect on RNK08954 in Healthy Participants, and the Mass Balance Study of [14C]RNK08954 in Healthy Adult Male Subjects

Start: Dec 2025Est. completion: Dec 202624 patients
Phase 1Not Yet Recruiting
NCT02017236HutchmedVolitinib

A Food Effect Phase I Study of the Volitinib in Healthy Subjects

Start: Nov 2013Est. completion: Jun 201425 patients
Phase 1Completed
NCT01322464Jazz PharmaceuticalsSativex

Study to Assess Food Effect on Sativex Bioavailability

Start: Jan 2008Est. completion: Feb 200825 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.